Page 7 of articles about PCV2
Updating on the epidemiology of PCV2 and implications
Novelties about the excretion routes, the transmission routes, the risk factors, etc., and explanation about how the PCV2 becomes a pathogenic virus.
Cost of post-weaning multi-systemic wasting syndrome and PCV2 subclinical infection – a stochastic economic model
Preliminary study of Porcine circovirus type 2 and Torque teno sus virus coinfection frequencies in Brazilian pig herds
Effect of the viraemia due to the porcine circovirus type 2 (PCV2) on production parameters
The most effective way of avoiding the production losses associated with the PCV2 consists in avoiding the appearance of the viraemia by inducing a passive or an active immunity that minimizes the circulation of the virus in the farm.
Fetal infections and antibody profiles in pigs naturally infected with porcine circovirus type 2 (PCV2)
Torque Teno sus virus type 2 (TTSuV2) loads in serum are increased in the background of diseases affecting the immune system
Frequent questions about PCV2 infection of breeding herds
A summary of current knowledge to address frequently asked questions from producers and practitioners on PCV2-associated reproductive disease.
Now FosteraTM PCV offers flexible dosing to help prevent PCV2 viremia
Effects of a PCV2 subclinical infection upon immunological parameters following an ADV vaccination
Interest of the serological tests related to PCV2
Given the high prevalence of the infection due to the PCV2 and its presence in healthy and sick animals, the serological tests against this pathogen have been questioned as a diagnostic test.